Proteomic assay assigns biological ages to 11 organs in 44,498 UK Biobank participants, linking deviations to future disease

Investigators measured nearly 3,000 circulating proteins, isolating 15% with predominant single-organ origin, then trained algorithms against age-adjusted population means to quantify deviation in standard deviations for brain, heart, lung, kidney, liver, pancreas, intestine, muscle, artery, immune, and adipose compartments. One-third of participants showed at least one organ exceeding 1.5 SD from the mean, with brain age most strongly predicting all-cause mortality. The study captured longitudinal health records but relied on baseline blood draws without serial sampling or direct tissue validation.

This approach extends earlier epigenetic clocks by resolving system-level heterogeneity, revealing that accelerated organ aging often precedes clinical diagnosis by years and aligns with emerging multi-omics efforts in preventive cardiology and neurodegeneration. It highlights an underappreciated pattern: individuals with youthful brains despite aged peripheral organs retain survival advantage, suggesting central regulatory roles that current risk models overlook.

Remaining gaps include lack of ethnic diversity beyond UK Biobank demographics, absence of intervention data showing whether lifestyle or pharmacologic modulation alters organ-age trajectories, and uncertainty about protein leakage versus active signaling as the mechanistic driver. Next steps require prospective cohorts with repeated proteomics and randomized trials of organ-age-stratified prevention.